HR 9 risk-assessment requirements would add $20 mil. to FDA premarket spending -- CBO.
This article was originally published in The Tan Sheet
Executive Summary
HR 9 RISK ASSESSMENT REQUIREMENTS WOULD ADD $20 MIL. TO FDA SPENDING for premarket regulatory activities each year, the Congressional Budget Office estimates in a report released Feb. 15. The $20 mil. in spending would result from the risk assessment requirement in Title III of the House Commerce Committee's version of the "Job Creation and Wage Enhancement Act" (HR 9).
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning